Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
Panayotis KaloyannidisAhmed AyyadZakaria BahaliwahBelal BlowiWael AlanaziZahra Al ShammasiHamdi ElsoudiIbrahim IbrahimHani Al HashmiPublished in: Bone marrow transplantation (2021)